Glyburide
- Product NDC
- 76333-154
- 11-digit product format
- 763330154
- Labeler code
- 76333
- Product ID
- 76333-154_79776664-132e-45ca-9d74-511ab4edc8ec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glyburide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Orient Pharma Co., Ltd.
- Application
- ANDA206483
- Marketing category
- ANDA
- Marketing start
- 2019-02-26
- Marketing end
- 0000-00-00
- Substance
- GLYBURIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 76333-154-11 | Glyburide | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
| 76333-154-12 | Glyburide | 1000 in 1 BOTTLE | TABLET | 1000 | | 2 |
| 76333-154-13 | Glyburide | 500 in 1 BOTTLE | TABLET | 500 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 76333-154 | GLYBURIDE TABLET [ORIENT PHARMA CO., LTD.] | 2 | Legacy NDC, 3 package rows | 20190226_3152f552-f0ac-4603-8110-3112e4d053b2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 76333-154-11 | 76333015411 | 100 TABLET in 1 BOTTLE (76333-154-11) | 100 tablet | 2019-02-26 | 0000-00-00 | No | No | Current |
| 76333-154-12 | 76333015412 | 1000 TABLET in 1 BOTTLE (76333-154-12) | 1000 tablet | 2019-02-26 | 0000-00-00 | No | No | Current |
| 76333-154-13 | 76333015413 | 500 TABLET in 1 BOTTLE (76333-154-13) | 500 tablet | 2019-02-26 | 0000-00-00 | No | No | Current |